Open

M. Avium Complex (MAC) Treatment Study for Pulmonary Infections

In this study, we want to compare two common treatments to learn how well they work and if there are any side effects when used to treat M. Avium Complex (MAC) pulmonary infections. The two regimens being compared are Azithromycin/Ethambutol vs Azithromycin/Ethambutol/Rifampin

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Location

United States (Nationwide)

What will be asked of you

During this study, you will be followed remotely by our study staff as we collect data from the testing (lab results, CT scans, breathing tests, etc.) and notes from the doctor treating you. You will also complete 4 sets of questionnaires throughout the study (either online or in person) about your symptoms, medication side effects, and quality of life.

Incentives

Up to $145 for completion of study questionnaires

Total length of participation:
12 Months

Looking for Specific Volunteers

Able to participate:

You have been diagnosed with M. Avium Complex Pulmonary Disease/Infection

Not eligible if:

Are already receiving antibiotic treatment for your M. Avium Complex Infection
You have a diagnosis of cystic fibrosis (CF)
You have a diagnosis of HIV/AIDS
You have ever received an organ transplant

Contact the Team

Visit Location

Jackson Pettee
Visit Study Website

100% Remote (online, phone, text)

Additional Study Information

Principal Investigator

Leigh Anne Daniels
Medicine-Pulmonary

Study Type

Clinical or Medical
Observational

Study Topics

Immune System/Infections
Lungs and Breathing

IRB Number

23-0152

ClinicalTrials.gov

NCT03672630

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.